Axogen Director Johnson Executes Classic Buy‑Sell Swap, Rebalancing Portfolio While Maintaining Long‑Term Stake
Axogen insider activity shows routine buy‑sell rebalancing, reflecting Johnson’s strategy of locking gains while keeping long‑term exposure. Investors see confidence in the stock’s value, yet the company’s growth hinges on its nerve‑regeneration pip…
4 minutes to read
